Related Experiment Video
Updated: Jun 11, 2026

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
Runx2 in normal tissues and cancer cells: A developing story
Karen Blyth1, Francois Vaillant, Alma Jenkins
1Beatson Institute for Cancer Research, Bearsden, Glasgow, UK. K.Blyth@beatson.gla.ac.uk
Runx transcription factors are crucial for development. Emerging evidence suggests Runx2 may promote cancer in various tissues, including bone, blood, and mammary and prostate glands.
Area of Science:
- Molecular Biology
- Developmental Biology
- Oncology
Background:
- Runx transcription factors are vital for mammalian development, particularly in hematopoietic and osteogenic lineages.
- Runx1 and CBFbeta are implicated in acute leukemia, suggesting broader roles for Runx genes in cancer.
- Runx2 is primarily known for its role in bone development.
Purpose of the Study:
- To explore the expression patterns and functions of Runx2 beyond its established role in bone development.
- To review the evidence for Runx2's involvement in neoplastic development across various cancer types.
Main Methods:
- Literature review of existing studies on Runx gene function and cancer.
- Analysis of Runx2 expression patterns in different tissues and cancer types.
- Synthesis of evidence regarding Runx2's role as a tumor promoter or suppressor.
Main Results:
- Runx2 exhibits expression and functions beyond the osteogenic lineage.
- Evidence indicates Runx2 can promote neoplastic development in hematopoietic lineages.
- Runx2 is implicated in the progression of advanced mammary and prostate cancers.
Conclusions:
- Runx transcription factors, including Runx2, have multifaceted roles in mammalian development and cancer.
- Runx2's functions extend beyond bone development, with significant implications in various cancers.
- Further research into Runx2's oncogenic roles is warranted for therapeutic strategies.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...